Next Article in Journal
Prediction of Placental Barrier Permeability: A Model Based on Partial Least Squares Variable Selection Procedure
Previous Article in Journal
Synthesis, Molecular Structure and Spectroscopic Investigations of Novel Fluorinated Spiro Heterocycles
 
 
Article

Celastrol Protects against Antimycin A-Induced Insulin Resistance in Human Skeletal Muscle Cells

1
Department of Bioprocess Engineering, Faculty of Chemical Engineering, Universiti Teknologi Malaysia, 81310 Johor Bahru, Johor, Malaysia
2
Innovation Centre in Agritechnology for Advanced Bioprocessing (ICA), Universiti Teknologi Malaysia, 81310 Skudai, Johor, Malaysia
3
Institute of Bioproduct Development, Universiti Teknologi Malaysia, 81310 Johor Bahru, Johor, Malaysia
4
Department of Pharmacy, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
5
Clinical Investigation Centre, 13th Floor Main Tower, University Malaya Medical Centre, 59100 Lembah Pantai, Kuala Lumpur, Malaysia
*
Authors to whom correspondence should be addressed.
Academic Editor: Maurizio Battino
Molecules 2015, 20(5), 8242-8269; https://doi.org/10.3390/molecules20058242
Received: 30 March 2015 / Revised: 29 April 2015 / Accepted: 4 May 2015 / Published: 7 May 2015
(This article belongs to the Section Medicinal Chemistry)
Mitochondrial dysfunction and inflammation are widely accepted as key hallmarks of obesity-induced skeletal muscle insulin resistance. The aim of the present study was to evaluate the functional roles of an anti-inflammatory compound, celastrol, in mitochondrial dysfunction and insulin resistance induced by antimycin A (AMA) in human skeletal muscle cells. We found that celastrol treatment improved insulin-stimulated glucose uptake activity of AMA-treated cells, apparently via PI3K/Akt pathways, with significant enhancement of mitochondrial activities. Furthermore, celastrol prevented increased levels of cellular oxidative damage where the production of several pro-inflammatory cytokines in cultures cells was greatly reduced. Celastrol significantly increased protein phosphorylation of insulin signaling cascades with amplified expression of AMPK protein and attenuated NF-κB and PKC θ activation in human skeletal muscle treated with AMA. The improvement of insulin signaling pathways by celastrol was also accompanied by augmented GLUT4 protein expression. Taken together, these results suggest that celastrol may be advocated for use as a potential therapeutic molecule to protect against mitochondrial dysfunction-induced insulin resistance in human skeletal muscle cells. View Full-Text
Keywords: celastrol; mitochondrial dysfunction; inflammation; human skeletal muscle; nuclear factor kappa B celastrol; mitochondrial dysfunction; inflammation; human skeletal muscle; nuclear factor kappa B
Show Figures

Graphical abstract

MDPI and ACS Style

Abu Bakar, M.H.; Cheng, K.-K.; Sarmidi, M.R.; Yaakob, H.; Huri, H.Z. Celastrol Protects against Antimycin A-Induced Insulin Resistance in Human Skeletal Muscle Cells. Molecules 2015, 20, 8242-8269. https://doi.org/10.3390/molecules20058242

AMA Style

Abu Bakar MH, Cheng K-K, Sarmidi MR, Yaakob H, Huri HZ. Celastrol Protects against Antimycin A-Induced Insulin Resistance in Human Skeletal Muscle Cells. Molecules. 2015; 20(5):8242-8269. https://doi.org/10.3390/molecules20058242

Chicago/Turabian Style

Abu Bakar, Mohamad Hafizi, Kian-Kai Cheng, Mohamad Roji Sarmidi, Harisun Yaakob, and Hasniza Zaman Huri. 2015. "Celastrol Protects against Antimycin A-Induced Insulin Resistance in Human Skeletal Muscle Cells" Molecules 20, no. 5: 8242-8269. https://doi.org/10.3390/molecules20058242

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop